KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

Entries with Priority Areas Biosciences .

Women In Innovation £200K Funding Briefing - Webinar

Innovate UK  has up to £200,000 and a package of tailored support to award to businesswomen who have exciting ideas and the potential to become leaders in innovation and deliver significant economic growth. This is the first women only  Innovate UK competition  and is part of a new ‘infocus’ initiative to encourage diversity in innovation. Each of the 12 finalists in...
Read More About Women In Innovation £200K Funding Briefing - Webinar »

Space for Innovation

Space for Innovation 14-15 September, London A unique opportunity to build cross-sector relationships, learn, and explore how research in the unique environment of space is creating opportunities to meet key challenges here on Earth, and how you could get involved. A cross-section of expert speakers will give perspectives – including first-hand case studies – showing how...
Read More About Space for Innovation »

BIA publishes new report on UK biotech financing

The Bioindustry Association (BIA), working in partnership with Evaluate and the London Stock Exchange (LSE), has published a new report -  Money, momentum and maturity: UK biotech financing and deals in 2015/16  - looking at trends in follow-on funding, venture capital activity, the strength of the R&D pipeline and rate of regulatory approvals. 2015 saw an...
Read More About BIA publishes new report on UK biotech financing »

Life Sciences Hub Wales - Funding & Finance Opportunities

Join The Life Sciences Hub Wales in Llandudno on the 13th July for an opportunity to learn more about funding opportunities available. This event is not limited to life science opportunities; presenters will provide an overview of opportunities for innovations across all sectors. Free to attend including lunch, refreshments and a great chance to network. 9:30 ...
Read More About Life Sciences Hub Wales - Funding & Finance Opportunities »

Innovate UK - Introduce their sectors - health & life sciences

Agritech and Health sectors under one umbrella Here’s an obvious synergy in the work companies do to develop new, innovative ways of using bioscience and the way those new approaches are then used across the agriculture, food and health industries, so we’ve brought them under the same support umbrella – our Health and Life Sciences sector team. Innovate UK are also aligning the...
Read More About Innovate UK - Introduce their sectors - health & life sciences »

Biomedical Engineering Innovation Workshop

Fundamentals of CAD and Programming for medical device development. 24 & 25 August 2016 Department of Biomedical Engineering, University of Strathclyde, Wolfson Centre, 106 Rottenrow, Glasgow G4 ONW A two-day CPD hands-on workshop for clinicians, businesses and students in the medical device community looking to acquire and apply crucial skills for medical...
Read More About Biomedical Engineering Innovation Workshop »

The future of biopharmaceutical formulation - making better products with novel approaches

KTN Biopharmaceutical Formulation Group The future of biopharmaceutical formulation - making better products with novel approaches UCL, London Thursday 7th July, 2016 The KTN’s Biopharmaceutical Formulation Group will meet on 7th July at an event hosted by the EPSRC Centre for Innovative Manufacturing at UCL. The event is an opportunity to hear from industry and academia in...
Read More About The future of biopharmaceutical formulation - making better products with novel approaches »

Funding Opportunities for SMEs in the Healthcare Sector: Webinar

    Funding Opportunities for SMEs in the Healthcare Sector - Webinar T he Cell and Gene Therapy Catapult, the Knowledge Transfer Network and H2020 National Contact Points will deliver a webinar on 30 June 2016 to highlight the forthcoming opportunities in Horizon 2020 Healthcare...
Read More About Funding Opportunities for SMEs in the Healthcare Sector: Webinar »

Medicines Discovery – mapping the UK innovation landscape

The Knowledge Transfer Network (KTN) has today launched a  Medicines Discovery UK Landscape .  This new tool  is designed to map the innovation landscape in medicines discovery - showcasing the UK capabilities and enabling added leverage from external collaborations, from outsourcing to strategic partnerships. Dr Alexander Henzing,  Knowledge Transfer Manager at...
Read More About Medicines Discovery – mapping the UK innovation landscape »

Biotech sector catalysed by £1.7m Edinburgh facility

A £1.7 million centre offering large-scale bioprocessing facilities has opened in Edinburgh, the first facility of its kind in the UK and aiming to help businesses test and commercialise their concepts. Known as FlexBio, the Flexible Downstream Bioprocessing Centre at Heriot-Watt University will focus on research and projects that are ready to “scale up”, enabling them to carry...
Read More About Biotech sector catalysed by £1.7m Edinburgh facility »

The National Innovation Plan Survey

We live in exciting times and innovation will enable us to tackle some of our biggest challenges, from our energy supply and food security, to managing demographic change and the delivery of public services. The UK is home to some of the most exciting and innovative companies in Europe, it makes sense that when thinking about how government can be more innovative to ask those who are...
Read More About The National Innovation Plan Survey »

Science Photo Library opportunity for Scottish Life Sciences companies

For the past 12 years Lewis Houghton, the official photographer for the life sciences dinner, has been contributing to the Science Photo library ( http://www.sciencephoto.com ). He is currently looking for any Scottish Life Sciences companies that would benefit from him taking images for them that he can submit to the Science Photo Library - he would also supply the company...
Read More About Science Photo Library opportunity for Scottish Life Sciences companies »

New Collaboration Opportunities In Regenerative Medicine

New Collaboration Opportunities in Regenerative Medicine and Addressing Challenges to Clinical Adoption of Cell and Gene Therapies New Hunts House Guy’s campus King’s College London London SE1 1UL 14 th June 2016 The KTN in collaboration with Innovate UK, Cell and Gene Therapy Catapult, Department of Health and Kings College London are holding an event...
Read More About New Collaboration Opportunities In Regenerative Medicine »

Open Innovate UK Funding competition

Innovate UK is to invest up to  £15 million  in innovation projects in manufacturing and/or materials. These projects will focus on identified technical or commercial challenges which are set out in the competition scope. The aim of this competition is to stimulate and broaden innovation in manufacturing and materials.  Projects need to be led by a business and must...
Read More About Open Innovate UK Funding competition »

Opportunities for IB & SynBio in the New Innovate UK Delivery Plan

Innovate UK has recently published its new  Delivery Plan,  outlining the main ways in which it will invest around £561M in helping businesses to innovate and grow in the financial year 2016 to 2017, including: two broad Health and Life Sciences competitions two broad Manufacturing and Materials competitions two ‘open’ funding competitions...
Read More About Opportunities for IB & SynBio in the New Innovate UK Delivery Plan »

Overcoming Cellular Barriers: Implications for Industrial Biotechnology

Overcoming Cellular Barriers: Implications for Industrial Biotechnology July 6th and 7th 2016, Birmingham Hilton Metropole The function of membranes in bacterial, yeast and mammalian cell factories are an important but underappreciated parameter in optimizing recombinant protein quality and yields.  In addition, the delivery of a therapeutic protein to its target...
Read More About Overcoming Cellular Barriers: Implications for Industrial Biotechnology »

MRC announces cross-council awards worth nearly £10m to tackle antibiotic resistance

Three large collaborative grants, totalling £9.5m, have been announced by the MRC as part of a cross-council initiative to tackle antimicrobial resistance (AMR). The awards together mark one of the biggest investments into AMR since the initiative launched and will use new technology to exploit natural compounds, develop a tool to offer better and faster diagnostics and explore how the...
Read More About MRC announces cross-council awards worth nearly £10m to tackle antibiotic resistance »

Oxstem closes record £16.9M fundraising round to design Stem Cell drugs to treat age-related disease

One of the most ambitious Oxford spinouts to date is on route to becoming a powerhouse in age-related regenerative medicine, developing drugs which can treat cancer, neurodegenerative diseases, heart failure, macular degeneration and other major age-related conditions. OxStem has raised a record £16.9m, and established strategic partnerships with world class biotechnology companies and...
Read More About Oxstem closes record £16.9M fundraising round to design Stem Cell drugs to treat age-related disease »

How the UK Is Driving a Global Revolution of 21st Century Healthcare Innovation

Technology is transforming healthcare. The pace of biomedical science and genetics is leading to the discovery of new diagnostics and new drugs at an extraordinary pace. Cancer for example is now becoming a treatable and in some cases curable and preventable disease. Digitalisation is transforming individual care, systems safety and performance, and research. It is putting patients in...
Read More About How the UK Is Driving a Global Revolution of 21st Century Healthcare Innovation »

Project Activation at the National Formulation Centre - webinar

Project Activation at the National Formulation Centre - webinar 24th May In the 2014 Autumn Statement, the Chancellor of the Exchequer awarded the Centre for Process Innovation (CPI) £28 million to establish the National Formulation Centre (NFC), part of the High Value Manufacturing Catapult, to be based at NetPark, Sedgefield. It was announced that 'the new centre would bring...
Read More About Project Activation at the National Formulation Centre - webinar »

MedImmune and Regeneron Enter into Licensing Agreement for the Development of Antibody Drug Conjugates to Treat Cancer

MedImmune, the global biologics research and development arm of AstraZeneca and Regeneron Pharmaceuticals, Inc., today announced that they have entered into a licensing agreement under which Regeneron will use MedImmune’s pyrrolobenzodiazepine (PBD)-based warhead and linker technology to produce antibody-drug conjugates (ADCs) as potential cancer treatments. Regeneron will have exclusive...
Read More About MedImmune and Regeneron Enter into Licensing Agreement for the Development of Antibody Drug Conjugates to Treat Cancer »

Universal flu vaccine under development by Oxford spinout Vaccitech

Universal flu vaccine developed at Oxford already showing promise in Phase II clinical trials Large investment of £10m from Oxford Sciences Innovation Further programs include vaccines to boost cancer immunotherapies Oxford spin out company Vaccitech has launched today with £10m seed investment to develop a universal flu vaccine already showing promise in clinical...
Read More About Universal flu vaccine under development by Oxford spinout Vaccitech »

Funding competition: manufacturing and materials

Innovate UK is to invest up to £15 million in innovation projects in manufacturing and/or materials. Innovate UK is to invest up to £15 million in innovation projects in manufacturing and/or materials. These projects will focus on identified technical or commercial challenges. We will fund projects that aim to lead to increased UK SME productivity, competitiveness and growth. ...
Read More About Funding competition: manufacturing and materials »

Innovate UK invests £561 million to back cutting-edge UK firms

Delivery Plan for the year 2016 to 2017 shows how Innovate UK will invest £561 million, with a more focused approach to innovation support. Innovate UK is to invest £561 million in innovation over the next 12 months and take a more focused and efficient approach to supporting innovative UK companies. The delivery plan for the year 2016 to 2017 includes: a new sector focus that is...
Read More About Innovate UK invests £561 million to back cutting-edge UK firms »

Blueberry Therapeutics raises £3M to progress the development of its lead topical antifungal

Blueberry Therapeutics today announced that it has raised £3 million to progress the development of its topical fungal infection therapies into human clinical trials. The investment was led by the GM&C Life Sciences Fund, managed by Catapult Ventures, and included participation from San Francisco-based InClin Investments, as well as a number of private investors. The investment will...
Read More About Blueberry Therapeutics raises £3M to progress the development of its lead topical antifungal »
Showing 1 - 25 of 61 results.
Items per Page 25
of 3